Pharmacovigilance research is imperative in informing better pharmaceutical practice, policy and treatment related to drug safety and effectiveness. The ODPRN has conducted multiple studies evaluating the real-world comparative effectiveness of drug therapies, drug-drug interactions, and potential adverse events associated with numerous drugs.
The Opioid Mortality Surveillance Report: Analysis of opioid-related deaths in Ontario July 2017 – June 2018
There is a need to better characterize and understand the factors that lead to opioid-related deaths in Ontario. The Ontario Drug Policy Research Network, the Office of the Chief Coroner for Ontario and Public Health Ontario have co-published a report that describes the current trends and characteristics of confirmed opioid-related deaths in Ontario between July 1, 2017 and June 30, 2018.
The report aims to advance understanding of the current rise of opioid-related deaths, as well as inform public health practice and system planning that addresses opioid-related harms in the province.
Access the full report and associated resources: